Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Sales (2016 - 2025)

Historic Return on Sales for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 0.15%.

  • Collegium Pharmaceutical's Return on Sales rose 900.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.07% for FY2024, which is 100.0% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Return on Sales stood at 0.15% for Q3 2025, which was up 900.0% from 0.06% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Return on Sales registered a high of 0.88% during Q2 2021, and its lowest value of 0.91% during Q4 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.07% (2024), whereas its average is 0.05%.
  • In the last 5 years, Collegium Pharmaceutical's Return on Sales tumbled by -10100bps in 2021 and then skyrocketed by 8600bps in 2022.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Return on Sales stood at 0.91% in 2021, then soared by 94bps to 0.06% in 2022, then soared by 484bps to 0.21% in 2023, then plummeted by -68bps to 0.07% in 2024, then surged by 118bps to 0.15% in 2025.
  • Its Return on Sales was 0.15% in Q3 2025, compared to 0.06% in Q2 2025 and 0.01% in Q1 2025.